The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Epstein-Barr virus provides a survival factor to Burkitt's lymphomas
Open accessAbstract
Epstein-Barr virus (EBV) has been causally associated with at least five human malignancies. The exact contributions made by EBV to these cancers remain unknown. We demonstrate that one viral protein found in all EBV-associated malignancies, Epstein-Barr nuclear antigen 1 (EBNA-1), is required for survival of one of these cancers, EBV-positive Burkitt's lymphoma. Inhibition of EBNA-1 decreases survival of these tumor cells by inducing apoptosis. Expression of EBNA-1 in uninfected cells also can inhibit apoptosis induced by expression of p53 in the absence of the EBV genome. Our findings demonstrate that EBNA-1 is critical for the continued survival of EBV-associated Burkitt's lymphoma, and, by extension, for the other B cell tumors with which EBV is associated. Efficient inhibitors of EBNA-1's functions would likely prove useful in the therapy of EBV-associated malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
p53 and E2F-1 cooperate to mediate apoptosis.
Wu, X., & Levine, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3602 · Cited by 839
EBV Persistence in Memory B Cells In Vivo
Babcock, G. J., Decker, L. L., Volk, M., & Thorley-Lawson, D. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80622-6 · Cited by 825
Rowe, M., Rowe, D. T., Gregory, C. D., Young, L. S., Farrell, P. J., Rupani, H., & Rickinson, A. B. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02568.x · Cited by 711
p53 inhibition by the LANA protein of KSHV protects against cell death
Friborg, J., Kong, W.-P., Hottiger, M. O., & Nabel, G. J. (1999) · Nature · doi:10.1038/47266 · Cited by 704
Translocations involving c-myc and c-myc function
Boxer, L. M., & Dang, C. V. (2001) · Oncogene · doi:10.1038/sj.onc.1204595 · Cited by 479
Rickinson, A. B., Young, L. S., & Rowe, M. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1310-1317.1987 · Cited by 369
Klein, G., Lindahl, T., Jondal, M., Leibold, W., Menézes, J., Nilsson, K., & Sundström, C. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.8.3283 · Cited by 331
Epstein–Barr virus RNA confers resistance to interferon‐α‐induced apoptosis in Burkitt's lymphoma
Nanbo, A., Inoue, K., Adachi‐Takasawa, K., & Takada, K. (2002) · The EMBO Journal · doi:10.1093/emboj/21.5.954 · Cited by 326
Evidence for a Large Compartment of IgM-Expressing Memory B Cells in Humans
Klein, U., Küppers, R., & Rajewsky, K. (1997) · Blood · doi:10.1182/blood.v89.4.1288 · Cited by 315
Shimizu, N., Tanabe-Tochikura, A., Kuroiwa, Y., & Takada, K. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.6069-6073.1994 · Cited by 291
Ben‐bassats, H., GOLDBLUM, N., Mitrani‐Rosenbaum, S., Goldblum, T., Yoffey, J. M., Cohen, M. M., Bentwich, Z., Ramot, B., Klein, E., & Klein, G. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910190105 · Cited by 275
Oncogenic Role of Epstein-Barr Virus-Encoded RNAs in Burkitt’s Lymphoma Cell Line Akata
Komano, J. A., Maruo, S., Kurozumi, K., Oda, T., & Takada, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.9827-9831.1999 · Cited by 268
Self-citationp53 is frequently mutated in Burkitt's lymphoma cell lines
Farrell, P. J., Allan, G. J., Shanahan, F., Vousden, K. H., & Crook, T. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07837.x · Cited by 254
Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells.
Kavathas, P., Bach, F. H., & DeMars, R. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4251 · Cited by 252
An Epstein-Barr virus-producer line Akata: Establishment of the cell line and analysis of viral DNA
Takada, K., Horinouchi, K., Ono, Y., Aya, T., Osato, T., Takahashi, M., & Hayasaka, S. (1991) · Virus Genes · doi:10.1007/bf00571929 · Cited by 228
Kelly, G., Bell, A., & Rickinson, A. (2002) · Nature Medicine · doi:10.1038/nm758 · Cited by 228
Kitagawa, N. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6742 · Cited by 202
Rapid induction of senescence in human cervical carcinoma cells
Goodwin, E. C., Yang, E., Lee, C.-J., Lee, H.-W., DiMaio, D., & Hwang, E.-S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.10978 · Cited by 176
Epstein-Barr virus infection and human malignancies.
Niedobitek, G., Meru, N., & Delecluse, H. (2001) · PubMed · doi:10.1046/j.1365-2613.2001.iep0082-0149-x · Cited by 161
Role of genetic and epigenetic changes in Burkitt lymphoma
Lindström, M. S., & Wiman, K. G. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00058-5 · Cited by 135
Epstein-Barr Virus Regulates c-MYC, Apoptosis, and Tumorigenicity in Burkitt Lymphoma
Ruf, I. K., Rhyne, P., Yang, H. J., Borza, C. M., Hutt‐Fletcher, L. M., Cleveland, J. L., & Sample, J. T. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1651 · Cited by 127
Wu, H., Kapoor, P., & Frappier, L. (2002) · Journal of Virology · doi:10.1128/jvi.76.5.2480-2490.2002 · Cited by 125
Epstein‐Barr virus infection and human malignancies
Niedobitek, G., Meru, N., & Delecluse, H. (2001) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2001.iep190.x · Cited by 123
p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53
Lindström, M. S., Klangby, U., & Wiman, K. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204303 · Cited by 111
Epstein-Barr virus DNA is amplified in transformed lymphocytes
Sugden, B., Phelps, M., & Domoradzki, J. Y. (1979) · Journal of Virology · doi:10.1128/jvi.31.3.590-595.1979 · Cited by 107
Self-citationThe Linking Regions of EBNA1 Are Essential for Its Support of Replication and Transcription
Mackey, D. M., & Sugden, B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3349 · Cited by 104
Self-citationDominant-negative inhibitors of EBNA-1 of Epstein-Barr virus
Kirchmaier, A. L., & Sugden, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.3.1766-1775.1997 · Cited by 98
Self-citationThe life and death of a B cell
Defrance, T., Casamayor‐Palleja, M., & Krammer, P. H. (2002) · Advances in cancer research · doi:10.1016/s0065-230x(02)86006-7 · Cited by 95
EBNA-1, a Bifunctional Transcriptional Activator
Kennedy, G. D., & Sugden, B. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.19.6901-6908.2003 · Cited by 92
Self-citationNonkwelo, C., Ruf, I. K., & Sample, J. T. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6887-6897.1997 · Cited by 68
Weigel, R. J., & Millert, G. (1983) · Virology · doi:10.1016/0042-6822(83)90202-7 · Cited by 68
Goodwin, E. C., & DiMaio, D. (2001) · PubMed · Cited by 66
Sternas, L. A., Middleton, T. L., & Sugden, B. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2407-2410.1990 · Cited by 61
Self-citationNilsson, K. (1992) · PubMed · Cited by 56
Cited by
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Epstein–Barr virus: more than 50 years old and still providing surprises
Young, L. S., Yap, L. F., & Murray, P. G. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.92 · Cited by 856
Epstein-Barr virus: Biology and clinical disease
Damania, B., Kenney, S. C., & Raab-Traub, N. (2022) · Cell · doi:10.1016/j.cell.2022.08.026 · Cited by 612
Adult Burkitt leukemia and lymphoma
Blum, K. A., Lozanski, G., & Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2004-02-0405 · Cited by 579
Farrell, P. J. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-013023 · Cited by 541
Metadata
- Authors
- Kennedy, G., Komano, J., & Sugden, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2003-11-05
- Volume
- 100
- Issue
- 24
- Pages
- 14269-14274
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1994723579
- Cited by
- 276
- References
- 35
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.